Drug interactions
Insulin glargine-lixisenatide + Semaglutide
Severity: Major
Insulin glargine-lixisenatide and Semaglutide: major interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Both products contain GLP-1 receptor agonist and insulin activity, and combining lixisenatide with semaglutide duplicates GLP-1 therapy. This adds gastrointestinal adverse effects and hypoglycemia risk without proven added benefit.
What this interaction means in plain words
Insulin glargine-lixisenatide and Semaglutide can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Insulin glargine-lixisenatide belongs to Endocrine; Semaglutide belongs to Endocrine.
Why it happens
Therapeutic duplication of GLP-1 receptor agonism, additive to insulin glucose lowering.
What to do
Avoid using two GLP-1 receptor agonists together; choose one agent. If a switch is made, stop one and monitor glucose and adjust insulin.
What to ask your pharmacist
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Insulin glargine-lixisenatide and Semaglutide, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Insulin glargine-lixisenatide
- Albiglutide + Insulin glargine-lixisenatide Major
- Chlorpropamide + Insulin glargine-lixisenatide Major
- Dulaglutide + Insulin glargine-lixisenatide Major
- Ethanol + Insulin glargine-lixisenatide Major
- Exenatide injectable + Insulin glargine-lixisenatide Major
- Glimepiride + Insulin glargine-lixisenatide Major
Other interactions of Semaglutide
- Insulin degludec-liraglutide + Semaglutide Major
- Chlorpropamide + Semaglutide Moderate
- Gliclazide + Semaglutide Moderate
- Glimepiride-pioglitazone + Semaglutide Moderate
- Glimepiride + Semaglutide Moderate
- Glipizide-metformin + Semaglutide Moderate
Frequently asked questions
Can I take Insulin glargine-lixisenatide with Semaglutide?
MediHelp rates the interaction as major. Insulin glargine-lixisenatide and Semaglutide can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Both products contain GLP-1 receptor agonist and insulin activity, and combining lixisenatide with semaglutide duplicates GLP-1 therapy. This adds gastrointestinal adverse effects and hypoglycemia risk without proven added benefit.
How serious is the interaction between Insulin glargine-lixisenatide and Semaglutide?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid using two GLP-1 receptor agonists together; choose one agent. If a switch is made, stop one and monitor glucose and adjust insulin.
What other medicines interact with Insulin glargine-lixisenatide?
MediHelp also lists interactions of Insulin glargine-lixisenatide with, for example, Albiglutide, Chlorpropamide, Dulaglutide. The full list is on the Insulin glargine-lixisenatide page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
